AAAAAA
Results:
1-16
|
Results: 16
Authors:
Jungers, P
Choukroun, G
Oualim, Z
Robino, C
Nguyen, AT
Man, NK
Citation: P. Jungers et al., Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients, NEPH DIAL T, 16(2), 2001, pp. 307-312
Authors:
Jungers, P
Massy, ZA
Nguyen-Khoa, T
Choukroun, G
Robino, C
Fakhouri, F
Touam, M
Nguyen, AT
Grunfeld, JP
Citation: P. Jungers et al., Longer duration of predialysis nephrological care is associated with improved long-term survival of dialysis patients, NEPH DIAL T, 16(12), 2001, pp. 2357-2364
Authors:
Choukroun, G
Citation: G. Choukroun, Prevention and treatment of diabetes mellitus type 1, PRESSE MED, 30(24), 2001, pp. 21-23
Authors:
Fournier, A
Oprisiu, R
Mazouz, H
Moriniere, P
El Esper, N
Choukroun, G
Citation: A. Fournier et al., Low parathyroid hormone levels and higher risk of hip fractures and mortality, AM J KIDNEY, 38(1), 2001, pp. 222-223
Authors:
Sheridan, AM
Force, T
Yoon, HJ
O'Leary, E
Choukroun, G
Taheri, MR
Bonventre, JV
Citation: Am. Sheridan et al., PLIP, a novel splice variant of Tip60, interacts with group IV cytosolic phospholipase A(2), induces apoptosis, and potentiates prostaglandin production, MOL CELL B, 21(14), 2001, pp. 4470-4481
Authors:
Jungers, P
Robino, C
Choukroun, G
Touam, M
Fakhouri, F
Grunfeld, JP
Citation: P. Jungers et al., Evolution of the epidemiology of chronic renal failure and prediction of maintenance dialysis needs in France, NEPHROLOGIE, 22(3), 2001, pp. 91-97
Authors:
Fournier, A
Mazouz, H
Choukroun, G
Andrejak, M
Godefroy, O
Citation: A. Fournier et al., The lowering of blood pressure after stroke, LANCET, 358(9297), 2001, pp. 1995-1995
Authors:
Fournier, A
Solal, MEC
Oprisiu, R
Choukroun, G
Moriniere, PH
Bouillon, R
Citation: A. Fournier et al., 7-84 PTH or aluminum antagonism in the resistance of uremic bone to the remodeling effect of endogenous PTH?, KIDNEY INT, 59(6), 2001, pp. 2375-2376
Authors:
Fournier, A
Solal, MEC
Oprisiu, R
Mazouz, H
Morinire, P
Choukroun, G
Bouillon, R
Citation: A. Fournier et al., Optimal range of plasma concentration of true 1-84 parathyroid hormone in patients on maintenance dialysis, J CLIN END, 86(4), 2001, pp. 1840-1841
Authors:
Haq, S
Choukroun, G
Lim, H
Tymitz, KM
del Monte, F
Gwathmey, J
Grazette, L
Michael, A
Hajjar, R
Force, T
Molkentin, JD
Citation: S. Haq et al., Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure, CIRCULATION, 103(5), 2001, pp. 670-677
Authors:
Lee, KH
Hajjar, RJ
Matsui, T
Choukroun, G
Force, TL
Rosenzweig, A
Citation: Kh. Lee et al., Cardiac signal transduction, J NUCL CARD, 7(1), 2000, pp. 63-71
Authors:
Jungers, P
Choukroun, G
Robino, C
Massy, ZA
Taupin, P
Labrunie, M
Man, NK
Landais, P
Citation: P. Jungers et al., Epidemiology of end-stage renal disease in the Ile-de-France area: a prospective study in 1998, NEPH DIAL T, 15(12), 2000, pp. 2000-2006
Authors:
Jungers, P
Choukroun, G
Robino, C
Taupin, P
Labrunie, M
Man, NK
Landais, P
Citation: P. Jungers et al., Epidemiology of end-stage renal disease in the Ile-de-France district: a prospective cooperative study in 1998, NEPHROLOGIE, 21(5), 2000, pp. 239-246
Authors:
Haq, S
Choukroun, G
Kang, ZB
Ranu, H
Matsui, T
Rosenzweig, A
Molkentin, JD
Alessandrini, A
Woodgett, J
Hajjar, R
Michael, A
Force, T
Citation: S. Haq et al., Glycogen synthase kinase-3 beta is a negative regulator of cardiomyocyte hypertrophy, J CELL BIOL, 151(1), 2000, pp. 117-129
Authors:
Force, T
Rosenzweig, A
Choukroun, G
Hajjar, R
Citation: T. Force et al., Calcineurin inhibitors and cardiac hypertrophy, LANCET, 353(9161), 1999, pp. 1290-1292
Authors:
Choukroun, G
Hajjar, R
Fry, S
del Monte, F
Haq, S
Guerrero, JL
Picard, M
Rosenzweig, A
Force, T
Citation: G. Choukroun et al., Regulation of cardiac hypertrophy in vivo by the stress-activated protein kinases/c-Jun NH2-terminal kinases, J CLIN INV, 104(4), 1999, pp. 391-398
Risultati:
1-16
|